Daly J M, Dudrick S J, Copeland E M
Ann Surg. 1980 Nov;192(5):587-92. doi: 10.1097/00000658-198011000-00001.
Effects of nutritional repletion with intravenous hyperalimentation (IVH) on sequential skin test reactivity were evaluated in 160 malnourished cancer patients undergoing chemotherapy (76 patients), surgery (49 patients), radiation therapy (20 patients) and supportive care (15 patients). In the chemotherapy group, 45 patients had negative reactions initially, and 25 patients (55%) had at least one skin test convert to positive in an average period of 19 days of IVH. In the surgery group, 23 patients (46%) were initially positive and remained positive, 13 patients (24%) converted from negative to positive, and 13 patients (30%) remained negative or converted to negative. Postoperative complications occurred in 25% of positive reactors, compared with 69% (p < 0.01) of negative reactors. In the radiation therapy group, the skin tests of six patients (30%) remained positive, three patients (15%) converted from negative to positive and the skin tests of nine patients (45%) remained negative. In the supportive care group, the skin tests of 73% of the patients either remained positive or converted to positive with IVH within an average period of 11 days of treatment. Nutritional therapy with IVH was associated with restored skin test reactivity in 51% of malnourished cancer patients undergoing oncologic therapy. Radiation therapy was generally immunosuppressive despite adequate nutritional repletion. In surgical patients, positive skin test reactivity correlated directly with a favorable response to operative therapy.
对160例接受化疗(76例)、手术(49例)、放疗(20例)和支持治疗(15例)的营养不良癌症患者,评估了静脉高营养(IVH)营养补充对连续皮肤试验反应性的影响。在化疗组中,45例患者最初反应为阴性,25例患者(55%)在平均19天的IVH治疗期间至少有一次皮肤试验转为阳性。在手术组中,23例患者(46%)最初为阳性并保持阳性,13例患者(24%)从阴性转为阳性,13例患者(30%)保持阴性或转为阴性。阳性反应者术后并发症发生率为25%,而阴性反应者为69%(p<0.01)。在放疗组中,6例患者(30%)的皮肤试验保持阳性,3例患者(15%)从阴性转为阳性,9例患者(45%)的皮肤试验保持阴性。在支持治疗组中,73%的患者在平均11天的治疗期内,其皮肤试验要么保持阳性,要么经IVH转为阳性。接受肿瘤治疗的营养不良癌症患者中,51%通过IVH营养治疗使皮肤试验反应性恢复。尽管营养补充充足,但放疗通常具有免疫抑制作用。在手术患者中,阳性皮肤试验反应性与对手术治疗的良好反应直接相关。